Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment

Endocrinology

Volumn 151, Issue 12, 2010, Pages 5961-5970

  Rosene, Matthew L ^a   Wittmann, Gábor ^b   Arrojo E Drigo, Rafael ^a   Singru, Praful S ^b   Lechan, Ronald M ^b   Bianco, Antonio C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DEETHYLAMIODARONE; IODOTHYRONINE DEIODINASE TYPE 2; THYROID PEROXIDASE; THYROTROPIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FEEDBACK SYSTEM; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CELL LINE; IODIDE PEROXIDASE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; THYROTROPIN;

EID: 78649890094     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0553     Document Type: Article

References (39)

1. Reiffel JA, Estes 3rd NA, Waldo AL, Prystowsky EN, DiBianco R 1994 A consensus report on antiarrhythmic drug use. Clin Cardiol 17:103-116
2. Holt DW, Tucker GT, Jackson PR, Storey GC 1983 Amiodarone pharmacokinetics. Am Heart J 106:840-847
3. Plomp TA, van Rossum JM, Robles de Medina EO, van Lier T, Maes RA 1984 Pharmacokinetics and body distribution of amiodarone in man. Arzneimittelforschung 34:513-520
4. Martino E, Bartalena L, Bogazzi F, Braverman LE 2001 The effects of amiodarone on the thyroid. Endocr Rev 22:240-254
5. Krenning EP, Docter R, Bernard B, Visser T, Hennemann G 1982 Decreased transport of thyroxine (T4), 3,3′,5-triiodothyronine (T3) and 3,3′,5′-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs. FEBS Lett 140:229-233
6. Bakker O, van Beeren HC, Wiersinga WM 1994 Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein. Endocrinology 134:1665-1670
7. van Beeren HC, Bakker O, Wiersinga WM 1995 Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone alpha 1-receptor protein. Mol Cell Endocrinol 112:15-19
8. Bogazzi F, Bartalena L, Brogioni S, Burelli A, Raggi F, Ultimieri F, Cosci C, Vitale M, Fenzi G, Martino E 2001 Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level. Eur J Endocrinol 145:59-64
9. Koenig RJ 2005 Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid 15:835-840
10. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeold A, Bianco AC 2008 Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29:898-938
11. Aanderud S, Sundsfjord J, Aarbakke J 1984 Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes. Endocrinology 115:1605-1608
12. Hershman JM, Nademanee K, Sugawara M, Pekary AE, Ross R, Singh BN, DiStefano JJ, 3rd 1986 Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone. Acta Endocrinol (Copenh) 111:193-199
13. Gotzsche LS, Boye N, Laurberg P, Andreasen F 1989 Rat heart thyroxine 5′-deiodinase is sensitively depressed by amiodarone. J Cardiovasc Pharmacol 14:836-841
14. Ceppi JA, Gonzalez MR, Zaninovich AA 1988 [Effect of amiodarone on the conversion of thyroxine to triiodothyronine in the myocardium of rats in vivo and in vitro]. Medicina (B Aires) 48:29-32
15. Balsam A, Ingbar SH 1978 The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver. J Clin Invest 62:415-424
16. Sogol PB, Hershman JM, Reed AW, Dillmann WH 1983 The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5′- monodeiodination in rats. Endocrinology 113:1464-1469
17. Pekary AE, Hershman JM, Reed AW, Kannon R, Wang YS 1986 Amiodarone inhibits T4 to T3 conversion and alpha-glycerophosphate dehydrogenase and malic enzyme levels in rat liver. Horm Metab Res 18:114-118
18. Ceppi JA, Zaninovich AA 1989 Effects of amiodarone on 5′-deiodination of thyroxine to tri-iodothyronine in rat myocardium. J Endocrinol 121:431-434
19. Ha HR, Stieger B, Grassi G, Altorfer HR, Follath F 2000 Structure-effect relationships of amiodarone analogues on the inhibition of thyroxine deiodination. Eur J Clin Pharmacol 55:807-814
20. Hudig F, Bakker O, Wiersinga WM 1994 Amiodarone-induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA. FEBS Lett 341:86-90
21. Christoffolete MA, Ribeiro R, Singru P, Fekete C, da Silva WS, Gordon DF, Huang SA, Crescenzi A, Harney JW, Ridgway EC, Larsen PR, Lechan RM, Bianco AC 2006 Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxine-mediated pituitary thyrotropin feedback mechanism. Endocrinology 147:1735-1743
22. Fekete C, Lechan RM 2007 Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol 28:97-114
23. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-2533
24. Kaplan MM, Pan CY, Gordon PR, Lee JK, Gilchrest BA 1988 Human epidermal keratinocytes in culture convert thyroxine to 3,5,3′-triiodothyronine by type II iodothyronine deiodination: a novel endocrine function of the skin. J Clin Endocrinol Metab 66:815-822
25. Kaplan MM, Breitbart R 1984 Conversion of thyroxine to triiodothyronine in the anterior pituitary gland and the influence of this process on thyroid status. Horm Metab Res Suppl 14:79-85
26. Safran M, Fang SL, Bambini G, Pinchera A, Martino E, Braverman LE 1986 Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat. Am J Med Sci 292:136-141
27. Burger A, Dinichert D, Nicod P, Jenny M, Lemarchand-Beraud T, Vallotton MB 1976 Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest 58:255-259
28. Melmed S, Nademanee K, Reed AW, Hendrickson JA, Singh BN, Hershman JM 1981 Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J Clin Endocrinol Metab 53:997-1001
29. Nademanee K, Singh BN, Hendrickson JA, Reed AW, Melmed S, Hershman J 1982 Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation 66:202-211
30. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, Galton VA 2001 Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15:2137-2148
31. Kádár A, Sánchez E, Wittmann G, Singru P, Füzesi T, Marsili A, Larsen P, Liposits Z, Lechan R, Fekete C 2010 Distribution of hypophysiotropic thyrotropin-releasing hormone (TRH)-synthesizing neurons in the hypothalamic paraventricular nucleus of the mouse. J Comp Neurol
32. Fekete C, Kelly J, Mihaly E, Sarkar S, Rand WM, Legradi G, Emerson CH, Lechan RM 2001 Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology 142:2606-2613
33. Freitas BC, Gereben B, Castillo M, Kallo I, Zeold A, Egri P, Liposits Z, Zavacki AM, Maciel RM, Jo S, Singru P, Sanchez E, Lechan RM, Bianco AC. Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest 120:2206-2217
34. Falik R, Flores BT, Shaw L, Gibson GA, Josephson ME, Marchlinski FE 1987 Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects. Am J Med 82:1102-1108
35. Yusta B, Alarid ET, Gordon DF, Ridgway EC, Mellon PL 1998 The thyrotropin beta-subunit gene is repressed by thyroid hormone in a novel thyrotrope cell line, mouse T alphaT1 cells. Endocrinology 139:4476-4482
36. Tu HM, Kim SW, Salvatore D, Bartha T, Legradi G, Larsen PR, Lechan RM 1997 Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138:3359-3368
37. Suzuki H, Kadena N, Takeuchi K, Nakagawa S 1979 Effects of three-day oral cholecystography on serum iodothyronines and TSH concentrations: comparison of the effects among some cholecystographic agents and the effects of iopanoic acid on the pituitarythyroid axis. Acta Endocrinol (Copenh) 92:477-488
38. Le Bouter S, El Harchi A, Marionneau C, Bellocq C, Chambellan A, van Veen T, Boixel C, Gavillet B, Abriel H, Le Quang K, Chevalier JC, Lande G, Leger JJ, Charpentier F, Escande D, Demolombe S 2004 Long-term amiodarone administration remodels expression of ion channel transcripts in the mouse heart. Circulation 110:3028-3035
39. Berry MJ, Kates AL, Larsen PR 1990 Thyroid hormone regulates type I deiodinase messenger RNA in rat liver. Mol Endocrinol 4:743-748